Véronique Minard‐Colin

Author

Also Known As

V Minard, V Minard-Colin, V. Minard, V. Minard-Colin, V. Minard‐Colin, Veronique Minard, Veronique Minard Colin, Veronique Minard-Colin, Veronique Minard‐Colin, Veronique Minard–Colin

258

Publications

Citations

H-Index

113

Concepts

All Affiliations

Institut Gustave Roussy Institut Curie Université Paris-Saclay Inserm University of Padua

About

Véronique Minard‐Colin is an author at Institut Gustave Roussy specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	49	3.2K
2	Health Sciences	10	10	271
3	Cell Biology	3	3	1K
4	Public Health	1	1	20
5	Allergy	1	1	13

Véronique Minard‐Colin

109

Publications

5.9K

Citations

H-Index

Page 1

	Year	Citations
Munc13-4 Is Essential for Cytolytic Granules Fusion and Is Mutated in a Form of Familial Hemophagocytic Lymphohistiocytosis (FHL3) Jérôme Feldmann, Isabelle Callebaut, Graça Raposo, Cell Is MutatedLymphoid NeoplasiaHematological MalignancyGranulocyteMedicine	2003	916
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children Véronique Minard‐Colin, Anne Aupérin, Marta Pillon, New England Journal of Medicine	2020	298
Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial Gianni Bisogno, Gian Luca De Salvo, Christophe Bergeron, The Lancet Oncology OncologyMetronomic TherapyRms 2005Maintenance ChemotherapyPharmacotherapy	2019	231
Real‐Time Blood Plasma Polymerase Chain Reaction for Management of Disseminated Adenovirus Infection Marianne Leruez‐Ville, Véronique Minard‐Colin, Florence Lacaille, Clinical Infectious Diseases Diagnostic VirologyAdenovirus InfectionViral PersistenceDisseminated Adenovirus InfectionViral Diagnostics	2003	188
Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial Gianni Bisogno, Meriel Jenney, Christophe Bergeron, The Lancet Oncology OncologyMedicineDose-intensified DoxorubicinPathologyPharmacotherapy	2018	182
iPS-cell-derived microglia promote brain organoid maturation via cholesterol transfer Dong Shin Park, Tatsuya Kozaki, Satish Kumar Tiwari, Nature InflammationMedicineCerebral OrganoidBrain-immune InteractionNeuroscience	2023	173
CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: An immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trial Anne Gomez‐Brouchet, Claire Illac, Julia Gilhodes, OncoImmunology	2017	165
Vemurafenib in pediatric patients with <scp><i>BRAFV</i></scp><i>600E</i> mutated high‐grade gliomas Francisco Bautista, Angélo Paci, Véronique Minard‐Colin, Pediatric Blood & Cancer	2013	139
Molecular Screening for Cancer Treatment Optimization (MOSCATO-01) in Pediatric Patients: A Single-Institutional Prospective Molecular Stratification Trial Anne C. Harttrampf, Ludovic Lacroix, Marc Deloger, Clinical Cancer Research	2017	130
Clinical Impact of <i>NOTCH1</i> and/or <i>FBXW7</i> Mutations, <i>FLASH</i> Deletion, and <i>TCR</i> Status in Pediatric T-Cell Lymphoblastic Lymphoma Céline Callens, Frédéric Baleydier, Étienne Lengliné, Journal of Clinical Oncology	2012	127

Page 1